Decoding Oklo's Options Activity: What's the Big Picture? - Oklo ( NYSE:OKLO )
Investors with a lot of money to spend have taken a bearish stance on Oklo OKLO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
What the Options Market Tells Us About Reddit - Reddit ( NYSE:RDDT )
Investors with a lot of money to spend have taken a bullish stance on Reddit RDDT. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
China's DeepSeek Ups The Heat In OpenAI Rivalry, Upgrades V3 Model Improving Coding And Reasoning Capability - Alphabet ( NASDAQ:GOOG ) , Amazon.com ( NASDAQ:AMZN )
DeepSeek's V3 model improves reasoning and coding, boosting competition with OpenAI and other U.S. AI leaders. DeepSeek's success accelerates open-source AI adoption in China, reshaping global competition and challenging OpenAI's business model. Pelosi's latest AI pick skyrocketed 169% in just ...
Bitcoin Tests Key Bull Market Support At $88,000: What Does Technical Analysis Say?
Bitcoin's correction has brought it to the "bull market support band," a critical level for its next move. He believes early April macroeconomic data could determine Bitcoin's next major move. Feel unsure about the market's next move?
Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate - Kezar Life Sciences ( NASDAQ:KZR )
Zetomipzomib shows 31.3% complete biochemical response with steroid taper to ≤5 mg/day vs. 12.5% on placebo in autoimmune hepatitis patients No disease flares occurred in zetomipzomib-treated patients achieving CR, with a median response duration of 27.6 weeks.
China's Oversupplied Solar Sector Sees Hints Of Stabilization
The leading solar cell maker is looking for capital support from a Hong Kong listing to tide it over while it waits for recovery in its oversupplied sector Solar Space has filed for a Hong Kong IPO, reporting it swung from a profit in 2023 to a 1.29 billion yuan loss last year
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop - Cassava Sciences ( NASDAQ:SAVA )
Cassava Sciences' simufilam failed to meet co-primary endpoints in the Phase 3 REFOCUS-ALZ trial for mild-to-moderate Alzheimer's disease. Cassava will discontinue Alzheimer's drug development, phasing out the simufilam program by Q2 2025 after disappointing trial results.
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ultra Clean Holdings, Inc. ( UCTT ) - Ultra Clean Hldgs ( NASDAQ:UCTT )
NEW YORK, March 25, 2025 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Ultra ...